Marker Therapeutics Inc (NASDAQ: MRKR) stock closed at $5.40 on 7/24/24 after a major increase of 11.6%. Moreover, this advance was accompanied by unusually high trading volume at 193% of normal. The stock has declined -7.7% during the last week but has been exceptionally strong relative to the market over the last nine months.
Current PriceTarget Research Rating
With future capital returns forecasted to fall short of the cost of capital, MRKR is expected to be a modest Value Eraser.
Marker Therapeutics has a current Value Trend Rating of D (Negative). The Value Trend Rating reflects very contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. Marker Therapeutics has a very low Appreciation Score of 6 but a good Power Rating of 76, producing the Negative Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment